Picture of Cidara Therapeutics logo

CDTX — Cidara Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapNeutral

Brief: Cidara Therapeutics Restructures Workforce To Focus On Planned Clinical Development Of CD388

Sept 12 (Reuters) - Cidara Therapeutics Inc  CDTX.O :
    * CIDARA THERAPEUTICS RESTRUCTURES WORKFORCE TO FOCUS ON
PLANNED
CLINICAL DEVELOPMENT OF CD388
    * CIDARA THERAPEUTICS INC: PLANNED REDUCTION IMPACTS
APPROXIMATELY
30% OF CIDARA WORKFORCE
    * CIDARA THERAPEUTICS INC: CONTINUES BUSINESS DEVELOPMENT
DISCUSSIONS FOR ITS ONCOLOGY DFC PROGRAMS
    * CIDARA THERAPEUTICS: REDUCTION IN WORKFORCE TO FOCUS ON
CLINICAL
DEVELOPMENT OF CD388

Source text for Eikon:  ID:nGNX5ShNlV 
Further company coverage:  CDTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cidara Therapeutics

See all news